Relationship between the plasma concentration of paliperidone and the clinical and drug-induced extrapyramidal symptoms in elderly patients with schizophrenia-Reference-Cited by-同舟云学术

Relationship between the plasma concentration of paliperidone and the clinical and drug-induced extrapyramidal symptoms in elderly patients with schizophrenia

Published:2014-02-17 Issue:3 Volume:29 Page:244-250
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum. Psychopharmacol Clin Exp

Author:

Suzuki Hidenobu¹,Gen Keishi²,Otomo Masahiro²,Inoue Yuichi³,Hibino Hiroyuki⁴,Mikami Ayako⁵,Matsumoto Hideo⁶,Mikami Katsunaka⁶

Affiliation:

1. Department of Psychiatry; Suzuki Clinic; Tokyo Japan

2. Department of Psychiatry; Seimo Hospital; Gunma Japan

3. Shakomae Kokorono Clinic; Tokyo Japan

4. Department of Psychiatry; Fukui Kinen Hospital; Kanagawa Japan

5. Department of Clinical Pharmacology; Tokai University School of Medicine; Kanagawa Japan

6. Department of Psychiatry; Tokai University School of Medicine; Kanagawa Japan

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology,Neurology

Reference24 articles.

1. Dose-finding study of paliperidone ER based on striatal and extrastriatal dopamine D2 receptor occupancy inpatients with schizophrenia;Arakawa;Psychopharmacol (Ber1),2008

2. A rating scale for drug induced akathisia;Barnes;Br J Psychiatry,1989

3. Olanzapine: a systematic review and meta-regression of the relationships between dose, plasma concentration, receptor occupancy, and response;Bishara;J Clin Psychopharmacol,2013

4. The influence of hepatic impairment on the pharmacokinetics of paliperidone;Boom;Int J Clin Pharmacol Ther,2009

5. Drug-drug interactions associated with second-generation antipsychotics: considerations for clinicians and patients;Conley;Psychopharmacol Bull,2007

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics;The World Journal of Biological Psychiatry;2024-09

2. Assessing the Clinical Efficacy of Therapeutic Drug Monitoring for Risperidone and Paliperidone in Patients with Schizophrenia: Insights from a Clinical Data Warehouse;Pharmaceuticals;2024-07-03

3. Evidence for Therapeutic Drug Monitoring of Atypical Antipsychotics;Prague Medical Report;2024

4. Racial/Ethnic Differences in the Pharmacokinetics of Antipsychotics: Focusing on East Asians;Journal of Personalized Medicine;2022-08-24

5. Paliperidone-Associated Sialorrhea;Journal of Clinical Psychopharmacology;2022-08-08